The Consumer Healthcare Products Association isn't making predictions about the next administration's regulatory agenda, but the OTC drug industry trade group likes how President-elect Donald Trump thinks about business.
OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House
With the Trump administration ahead, CHPA's highest regulatory priorities include eliminating a requirement from the Obama era that consumers get a prescription in order to pay for OTC drugs with pre-tax savings accounts and improving the Nixon-era monograph program.
